AI Article Synopsis

Article Abstract

This study determined the relationship between vocational and educational plans, work values, vocational choice, awareness of occupational requirements, intelligence, self-esteem, and clinical severity of patients with cystic fibrosis and their school and vocational status six years after hospital clinical evaluation. Initially, 52 adolescents were tested on the Goldberg Vocational Development Scale, the Army General Classification Test, Tennessee Self-Concept Scale, and the Shwachman-Kulczycki System of Clinical Evaluation. Six years later each patient was sent a questionnaire to determine current school and employment. All data were subjected to intercorrelations (Pearson and biserial r) and analysis of variance. Eighteen survived and 15 responded. Ten were working in a variety of professional, semi-professional, and clerical jobs, two were unemployed due to cystic fibrosis, and three were still attending college. Of the 15, eight had graduated from college, nursing, or graduate school; one graduated from high school; three were full time students; and three were parttime students. The best predictors of school status were severity of illness (r = -0.55, p less than 0.01), and higher self esteem (r = 0.43, p less than 0.05). No single measure predicted work status. In a two-way analysis of variance using clinical severity and the average vocational development score, the main effect for severity (F = 4.19, p less than 0.05) was significant for student, but not for work status. It was concluded that the most powerful predictor of current student status was mild severity.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cystic fibrosis
12
clinical severity
8
clinical evaluation
8
vocational development
8
analysis variance
8
work status
8
status
6
vocational
5
severity
5
school
5

Similar Publications

Cystic fibrosis (CF) is a rare genetic disorder commonly affecting multiple organs such as the lungs, pancreas, liver, kidney, and intestine. Our search focuses on the pathophysiological changes that affect the drugs' absorption, distribution, metabolism, and excretion (ADME). This review aims to identify the ADME data that compares the pharmacokinetics (PK) of different drugs in CF and healthy subjects.

View Article and Find Full Text PDF

Perspectives in MicroRNA Therapeutics for Cystic Fibrosis.

Noncoding RNA

January 2025

Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, 44121 Ferrara, Italy.

The discovery of the involvement of microRNAs (miRNAs) in cystic fibrosis (CF) has generated increasing interest in the past years, due to their possible employment as a novel class of drugs to be studied in pre-clinical settings of therapeutic protocols for cystic fibrosis. In this narrative review article, consider and comparatively evaluate published laboratory information of possible interest for the development of miRNA-based therapeutic protocols for cystic fibrosis. We consider miRNAs involved in the upregulation of CFTR, miRNAs involved in the inhibition of inflammation and, finally, miRNAs exhibiting antibacterial activity.

View Article and Find Full Text PDF

Antimicrobial peptides (AMPs) are key components of innate immunity across all domains of life. Natural and synthetic AMPs are receiving renewed attention in efforts to combat the antimicrobial resistance (AMR) crisis and the loss of antibiotic efficacy. The gram-negative pathogen Pseudomonas aeruginosa is one of the most concerning infecting bacteria in AMR, particularly in people with cystic fibrosis (CF) where respiratory infections are difficult to eradicate and associated with increased morbidity and mortality.

View Article and Find Full Text PDF

Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discovery.

NPJ Antimicrob Resist

November 2024

College of Health and Life Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK.

Polymicrobial communities inhabit the cystic fibrosis (CF) airway, whereby microbial interactions can occur. One prominent CF pathogen is Mycobacterium abscessus, whose treatment is largely unsuccessful. This creates a need to discover novel antimicrobial agents to treat M.

View Article and Find Full Text PDF

Mycobacterium abscessus complex (MABSC) comprises a group of environmental microorganisms, which are a concerning cause of opportunistic respiratory infections in patients with cystic fibrosis or bronchiectasis. Only 45.6% of MABSC treatments are successful, and therefore this is a need to discover new antimicrobials that can treat these pathogens.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!